What is go.drugbank.com?
DrugBank, founded in 2006 and based in Alberta, Canada, operates as a critical bioinformatics and cheminformatics resource. The platform uniquely integrates detailed drug data with comprehensive drug target information, serving as an essential tool for researchers and developers in the pharmaceutical and life sciences industries. The company's recent major enterprise-level funding underscores its established position and potential for further expansion.
How much funding has go.drugbank.com raised?
go.drugbank.com has raised a total of $9M across 1 funding round:
Angel/Seed
$9M
Angel/Seed (2022): $9M with participation from Brightspark Ventures and Amplitude Ventures
Key Investors in go.drugbank.com
Brightspark Ventures
Brightspark Ventures is a Canadian venture capital firm established in 1999, specializing in providing growth capital and expertise to disruptive, market-transforming Canadian tech companies from seed to growth stages.
Amplitude Ventures
Amplitude Ventures is a Canadian precision medicine-focused venture capital firm that deploys a growth model to scale companies with world-class management teams, having launched its first private capital fund in November 2019.
What's next for go.drugbank.com?
With a recent major strategic investment, go.drugbank.com is poised to accelerate its development and market penetration. This capital will likely fuel advancements in its drug data and target information capabilities, potentially expanding its reach into new therapeutic areas or enhancing its analytical tools. The company's trajectory suggests a focus on scaling its operations and solidifying its role as a key player in the drug discovery and development ecosystem.
See full go.drugbank.com company page
